agilon health, inc. (NYSE:AGL - Free Report) - Investment analysts at Leerink Partnrs lowered their Q2 2025 earnings estimates for shares of agilon health in a note issued to investors on Wednesday, May 7th. Leerink Partnrs analyst W. Mayo now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their previous estimate of ($0.09). The consensus estimate for agilon health's current full-year earnings is ($0.59) per share. Leerink Partnrs also issued estimates for agilon health's Q3 2025 earnings at ($0.11) EPS, Q4 2025 earnings at ($0.11) EPS, FY2025 earnings at ($0.35) EPS, Q2 2026 earnings at ($0.06) EPS, Q3 2026 earnings at ($0.07) EPS, Q4 2026 earnings at ($0.08) EPS, FY2026 earnings at ($0.20) EPS and FY2027 earnings at ($0.14) EPS.
Other analysts have also recently issued research reports about the stock. Cowen reiterated a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. The Goldman Sachs Group raised their price objective on shares of agilon health from $2.50 to $5.00 and gave the company a "neutral" rating in a research note on Thursday. Citigroup upgraded shares of agilon health from a "neutral" rating to a "buy" rating and raised their price objective for the company from $3.25 to $5.00 in a research note on Friday, April 25th. Stifel Nicolaus raised their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research note on Wednesday, February 26th. Finally, Barclays raised their price objective on shares of agilon health from $2.00 to $3.00 and gave the company an "underweight" rating in a research note on Thursday. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $4.89.
View Our Latest Research Report on AGL
agilon health Stock Down 10.9%
AGL stock opened at $2.87 on Monday. agilon health has a one year low of $1.50 and a one year high of $7.73. The stock has a market capitalization of $1.19 billion, a PE ratio of -3.05 and a beta of 0.38. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The company has a fifty day moving average of $4.27 and a 200-day moving average of $3.19.
agilon health (NYSE:AGL - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.03 EPS for the quarter, topping the consensus estimate of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The company had revenue of $1.53 billion during the quarter, compared to analysts' expectations of $1.50 billion. During the same quarter last year, the business earned ($0.02) EPS. The business's revenue was down 4.5% on a year-over-year basis.
Institutional Investors Weigh In On agilon health
Hedge funds and other institutional investors have recently modified their holdings of the company. Oak Thistle LLC purchased a new stake in shares of agilon health during the fourth quarter worth about $25,000. Ieq Capital LLC purchased a new stake in agilon health in the fourth quarter valued at approximately $26,000. Signaturefd LLC grew its holdings in agilon health by 143.0% in the fourth quarter. Signaturefd LLC now owns 14,388 shares of the company's stock valued at $27,000 after purchasing an additional 8,467 shares during the period. Humankind Investments LLC purchased a new stake in agilon health in the fourth quarter valued at approximately $30,000. Finally, Raymond James Financial Inc. purchased a new stake in agilon health in the fourth quarter valued at approximately $33,000.
agilon health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.